Finally, activation of oncogenic signalling pathways including tyrosine kinase receptors (hepatocyte growth factor receptor (MET), Fibroblast Growth Factor 19 (FGF19), and Vascular Endothelial Growth Factor A (VEGFA)) has been described in HCC. This evidence concerns the gene MET and hepatocellular carcinoma.